ES2062786T3 - Microesferas, su procedimiento de preparacion y su utilizacion. - Google Patents

Microesferas, su procedimiento de preparacion y su utilizacion.

Info

Publication number
ES2062786T3
ES2062786T3 ES91908505T ES91908505T ES2062786T3 ES 2062786 T3 ES2062786 T3 ES 2062786T3 ES 91908505 T ES91908505 T ES 91908505T ES 91908505 T ES91908505 T ES 91908505T ES 2062786 T3 ES2062786 T3 ES 2062786T3
Authority
ES
Spain
Prior art keywords
biodegradable
microspheres
preparation procedure
polymer
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91908505T
Other languages
English (en)
Inventor
Gilles Spenlehauer
Michel Veillard
Thierry Verrechia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of ES2062786T3 publication Critical patent/ES2062786T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVAS MICROESFERAS BIODEGRADABLES Y BIOCOMPATIBLES CONSTITUIDAS POR UNO O VARIOS PRINCIPIOS ACTIVOS Y POR UN POLIMERO BIODEGRADABLE Y BIOCOMPATIBLE Y POR UNA SUSTANCIA TENSIOACTIVA, ELLA TAMBIEN BIODEGRADABLE Y BIOCOMPATIBLE. EL PROCESO CONSISTE EN PREPARAR UNA SOLUCION DEL POLIMERO Y DEL PRINCIPIO ACTIVO EN UN SOLVENTE NO MISCIBLE EN AGUA QUE SE MEZCLA A CONTINUACION EN LA SOLUCION ACUOSA DE TENSIOACTIVO SEGUIDO DE UNA EVAPORACION DEL SOLVENTE.
ES91908505T 1990-04-06 1991-04-04 Microesferas, su procedimiento de preparacion y su utilizacion. Expired - Lifetime ES2062786T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9004471A FR2660556B1 (fr) 1990-04-06 1990-04-06 Microspheres, leur procede de preparation et leur utilisation.

Publications (1)

Publication Number Publication Date
ES2062786T3 true ES2062786T3 (es) 1994-12-16

Family

ID=9395533

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91908505T Expired - Lifetime ES2062786T3 (es) 1990-04-06 1991-04-04 Microesferas, su procedimiento de preparacion y su utilizacion.

Country Status (8)

Country Link
EP (1) EP0523183B1 (es)
JP (1) JP3244502B2 (es)
CA (1) CA2076010C (es)
DE (1) DE69101144T2 (es)
DK (1) DK0523183T3 (es)
ES (1) ES2062786T3 (es)
FR (1) FR2660556B1 (es)
WO (1) WO1991015193A1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
AU642066B2 (en) * 1991-01-25 1993-10-07 Nanosystems L.L.C. X-ray contrast compositions useful in medical imaging
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
ES2034891B1 (es) * 1991-08-08 1993-12-16 Cusi Lab Procedimiento de elaboracion en continuo de sistemas coloidales dispersos, en forma de nanocapsulas o nanoparticulas.
CA2078388A1 (en) * 1991-10-02 1993-04-03 Mridula Nair Biocompatible emulsion particles
DE4227752A1 (de) * 1992-08-21 1994-02-24 Basf Ag Verfahren zur Herstellung von Alkylglykosiden
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US6537579B1 (en) 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
FR2721510B1 (fr) * 1994-06-22 1996-07-26 Rhone Poulenc Rorer Sa Nanoparticules filtrables dans des conditions stériles.
EP0805678B1 (en) * 1995-01-05 2003-10-29 THE BOARD OF REGENTS acting for and on behalf of THE UNIVERSITY OF MICHIGAN Surface-modified nanoparticles and method of making and using same
ES2177592T3 (es) * 1995-07-05 2002-12-16 Europ Economic Community Nanoparticulas biocompatibles y biodegradables para la absorcion y administracion de medicamentos proteinicos.
WO1997014407A1 (en) * 1995-10-17 1997-04-24 Research Triangle Pharmaceuticals Insoluble drug delivery
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
FR2742357B1 (fr) * 1995-12-19 1998-01-09 Rhone Poulenc Rorer Sa Nanoparticules stabilisees et filtrables dans des conditions steriles
US6143037A (en) * 1996-06-12 2000-11-07 The Regents Of The University Of Michigan Compositions and methods for coating medical devices
US8137684B2 (en) 1996-10-01 2012-03-20 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
FR2757768B1 (fr) * 1996-12-27 1999-04-02 Biovector Therapeutics Sa Vecteur particulaire homeocharge et composition pharmaceutique ou cosmetique le contenant
US5945126A (en) * 1997-02-13 1999-08-31 Oakwood Laboratories L.L.C. Continuous microsphere process
KR101180181B1 (ko) 1997-06-27 2012-09-05 아브락시스 바이오사이언스, 엘엘씨 나노 입자 및 그의 제조 방법
IT1293088B1 (it) * 1997-07-10 1999-02-11 Isi Ist Sierovaccinogeno Ital Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in
CA2276066A1 (en) * 1999-03-11 2000-09-11 Zycos Inc. Microparticles for delivery of nucleic acid
WO2001012071A1 (en) 1999-08-13 2001-02-22 Point Biomedical Corporation Microparticles useful as ultrasonic contrast agents and for lymphatic system
EP1202670A4 (en) 1999-08-13 2004-11-10 Point Biomedical Corp HOLLOW MICROSPHERES WITH CONTROLLED FRAGILITY FOR MEDICAL USE
US7147627B2 (en) 2002-08-21 2006-12-12 Hollister Incorporated Bowel management system
BRPI0409032A (pt) 2003-04-10 2006-05-02 Pr Pharmaceuticals método para a produção de micropartìculas à base de emulsão
CN1852687B (zh) 2003-07-15 2014-01-22 赢创有限公司 控释组合物的制备方法
BRPI0412211A (pt) * 2003-07-23 2006-08-22 Pr Pharmaceuticals Inc composições de liberação controlada
CA3054535A1 (en) 2005-02-18 2006-08-24 Abraxis Bioscience, Llc Combinations and modes of administration of therapeutic agents and combination therapy
US8735394B2 (en) 2005-02-18 2014-05-27 Abraxis Bioscience, Llc Combinations and modes of administration of therapeutic agents and combination therapy
EP2552415B1 (en) 2010-03-29 2016-09-07 Abraxis BioScience, LLC Methods of treating cancer
MX2012011155A (es) 2010-03-29 2012-12-05 Abraxis Bioscience Llc Metodos para mejorar suministros de farmacos y efectividad de agentes terapeuticos.
NZ706745A (en) 2010-06-04 2017-01-27 Abraxis Bioscience Llc Methods of treatment of pancreatic cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
CA1196864A (en) * 1983-06-10 1985-11-19 Mattheus F.A. Goosen Controlled release of injectable and implantable insulin compositions
JPS63122620A (ja) * 1986-11-12 1988-05-26 Sanraku Inc ポリ乳酸マイクロスフエア及びその製造方法
GB2207693A (en) * 1987-08-06 1989-02-08 Costain Concrete Company Limit Concrete railway sleepers

Also Published As

Publication number Publication date
EP0523183A1 (fr) 1993-01-20
EP0523183B1 (fr) 1994-02-02
WO1991015193A1 (fr) 1991-10-17
CA2076010A1 (fr) 1991-10-07
JP3244502B2 (ja) 2002-01-07
DE69101144T2 (de) 1994-05-26
DE69101144D1 (de) 1994-03-17
FR2660556B1 (fr) 1994-09-16
DK0523183T3 (da) 1994-05-09
CA2076010C (fr) 2004-05-18
JPH05507063A (ja) 1993-10-14
FR2660556A1 (fr) 1991-10-11

Similar Documents

Publication Publication Date Title
ES2062786T3 (es) Microesferas, su procedimiento de preparacion y su utilizacion.
ES2232022T3 (es) Material plastico esponjoso desinfectante.
ES2565991T3 (es) Composición terapéutica y uso
PE77399A1 (es) Composiciones limpiadoras liquidas suaves antimicrobianas que se quitan enjuagando que contienen acido salicilico
ES2060074T3 (es) Una preparacion farmaceutica de liberacion controlada y un metodo para su obtencion.
PE20010985A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
ES2062632T3 (es) Composicion para tratamiento del cabello.
BR0014549A (pt) Artigo elástico
PE79399A1 (es) Composiciones limpiadoras liquidas suaves antimicrobianas que se quitan enjuagando que contienen surfactantes acidos
UY24210A1 (es) Composicion de gel o de barra antitranspirante libre de pegajosidad, clara o translucida y metodo de fabricacion
ES2123278T3 (es) Procedimiento para producir un polimero superabsorbente mejorado.
AR077053A2 (es) Formulacion liquida concentrada desinfectante.
AR041435A1 (es) Articulo absorbente
CO5440227A1 (es) Composicion antihelmitica e inyectable mejorada de crecimiento
ES2151464T3 (es) Preparacion para aplicacion externa que comprende tranilast y procedimiento para producirla.
ES2050657T3 (es) Agente acuoso de tratamiento previo de vajilla.
AR065073A2 (es) Una formulacion medicamentosa de sistema de matriz que tiene liberacion controlada de un compuesto activo
PA8543901A1 (es) Producto cosmetico de dos fases de bolita (roll-on)
ES2069715T3 (es) Secuencia de oligonucleotidos antisentido, anti-arn mensajero del tnf alfa, procedimiento de preparacion, aplicacion como medicamentos y composiciones farmaceuticas.
ES2152016T3 (es) Solucion oftalmica de pranoprofeno conteniendo amina organica.
ES2118317T3 (es) Agente de lavado para la desinfeccion y descontaminacion de las manos a base de alcoholes aromaticos naturales.
ES2123790T3 (es) Procedimiento para la preparacion de biopolimeros yodados que tienen actividad desinfectante y cicatrizante, y los biopolimeros yodados obtenidos por dicho procedimiento.
UY23881A1 (es) Sistema surfactante mixto como revestimiento durable de tejido
BRPI0410958B8 (pt) composição aquosa agroquímica
ATE131075T1 (de) Superabsorbierender wundverband.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 523183

Country of ref document: ES